# Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-study-evaluating-trifluridine-tipiracil-bevacizumab-and-capecitabine/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Krzysztof Leśniewski-Kmak,В. Моисеенко,Mark Saunders,Harpreet Wasan,Guillem Argilés,Christophe Borg,Geert‐Jan Creemers,M. Fedyanin,Rob Glynne‐Jones,Per Pfeiffer,Cornelis J.A. Punt,Daniil Stroyakovskiy,A ten Tije,A. van de Wouw,Akira Kanehisa,Ronan Fougeray,Natividad Lopez Busto,Nadia Amellal,Eric Van Cutsem |
| Citations | 15 |
| DOI | 10.1093/annonc/mdy149.021 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.annalsofoncology.org/article/S0923753419337081/pdf |
| OpenAlex ID | https://openalex.org/W2809466198 |
| Type | article |
| Year | 2018 |

## Paper authors

- [В. Моисеенко](https://scholariq.org/researchers/a5112141652/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.